ANXA1 and androgen insensitivity syndrome: In conclusion, we report for the first time that the decreased ANXA1 in patients with AIS were recovered 2nd–3rd after successful recanalization by EVT, which were positively correlated with clinical outcomes, indicating circulating ANXA1 might be a potential prognostic biomarker.